In non-small cell lung cancer, a greater infiltration of CCL18-producing cells is associated with a better prognosis [183], although the level of this chemokine in the plasma of patients with this type of cancer is associated with a worse prognosis [175] (Table 1). This evidence concerns the gene CCL18 and non-small cell lung carcinoma.